Ontology highlight
ABSTRACT:
SUBMITTER: Johnson TW
PROVIDER: S-EPMC6142052 | biostudies-literature | 2018 Sep
REPOSITORIES: biostudies-literature
Johnson Ted W TW Bolanos Ben B Brooun Alexei A Gallego Rebecca A RA Gehlhaar Dan D Jalaie Mehran M McTigue Michele M Timofeevski Sergei S
ACS medicinal chemistry letters 20180824 9
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that can become oncogenic by activating mutations or overexpression. Full kinetic characterization of both phosphorylated and nonphosphorylated wildtype and mutant ALK kinase domain was done. Our structure-based drug design programs directed at ALK allowed us to interrogate whether X-ray crystallography data could be used to support the hypothesis that activation of ALK by mutation occurs due to increased protein dynamics. Crystallog ...[more]